vs
Side-by-side financial comparison of MNTN, Inc. (MNTN) and Valneva SE (VALN). Click either name above to swap in a different company.
MNTN, Inc. is the larger business by last-quarter revenue ($73.7M vs $36.2M, roughly 2.0× Valneva SE). MNTN, Inc. runs the higher net margin — 11.9% vs -54.1%, a 66.0% gap on every dollar of revenue.
MNTN Inc. is a U.S.-headquartered advertising technology firm specializing in performance-driven connected TV (CTV) advertising solutions. It serves e-commerce, retail, and consumer goods brands, helping clients accurately measure ad campaign ROI and reach targeted audiences across streaming TV platforms in North American and European markets.
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States.
MNTN vs VALN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2023
| Metric | | |
|---|---|---|
| Revenue | $73.7M | $36.2M |
| Net Profit | $8.8M | $-19.6M |
| Gross Margin | 2748.6% | 38.9% |
| Operating Margin | 31.5% | -49.5% |
| Net Margin | 11.9% | -54.1% |
| Revenue YoY | 14.2% | — |
| Net Profit YoY | 141.5% | — |
| EPS (diluted) | $0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $73.7M | — | ||
| Q3 25 | $70.0M | — | ||
| Q2 25 | $68.5M | — | ||
| Q1 23 | — | $36.2M | ||
| Q2 22 | — | $93.2M |
| Q1 26 | $8.8M | — | ||
| Q3 25 | $6.4M | — | ||
| Q2 25 | $-26.2M | — | ||
| Q1 23 | — | $-19.6M | ||
| Q2 22 | — | — |
| Q1 26 | 2748.6% | — | ||
| Q3 25 | 78.9% | — | ||
| Q2 25 | 76.8% | — | ||
| Q1 23 | — | 38.9% | ||
| Q2 22 | — | — |
| Q1 26 | 31.5% | — | ||
| Q3 25 | 10.8% | — | ||
| Q2 25 | 5.4% | — | ||
| Q1 23 | — | -49.5% | ||
| Q2 22 | — | -161.3% |
| Q1 26 | 11.9% | — | ||
| Q3 25 | 9.2% | — | ||
| Q2 25 | -38.3% | — | ||
| Q1 23 | — | -54.1% | ||
| Q2 22 | — | — |
| Q1 26 | $0.11 | — | ||
| Q3 25 | $0.08 | — | ||
| Q2 25 | $-0.65 | — | ||
| Q1 23 | — | — | ||
| Q2 22 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $213.9M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $318.6M | $221.2M |
| Total Assets | $375.1M | $637.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $213.9M | — | ||
| Q3 25 | $179.2M | — | ||
| Q2 25 | $175.2M | — | ||
| Q1 23 | — | $274.8M | ||
| Q2 22 | — | $363.1M |
| Q1 26 | $318.6M | — | ||
| Q3 25 | $266.7M | — | ||
| Q2 25 | $238.9M | — | ||
| Q1 23 | — | $221.2M | ||
| Q2 22 | — | $100.7M |
| Q1 26 | $375.1M | — | ||
| Q3 25 | $335.9M | — | ||
| Q2 25 | $337.0M | — | ||
| Q1 23 | — | $637.2M | ||
| Q2 22 | — | $783.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $7.1M | $-26.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 0.81× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $7.1M | — | ||
| Q3 25 | $9.3M | — | ||
| Q2 25 | $17.6M | — | ||
| Q1 23 | — | $-26.3M | ||
| Q2 22 | — | — |
| Q1 26 | 0.81× | — | ||
| Q3 25 | 1.45× | — | ||
| Q2 25 | — | — | ||
| Q1 23 | — | — | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
